Pancreatic atrophy after gastrectomy for gastric cancer

被引:2
作者
Takahashi, Ryo [1 ,2 ]
Nunobe, Souya [1 ]
Sai, Naohito [1 ]
Makuuchi, Rie [1 ]
Ida, Satoshi [1 ]
Kumagai, Koshi [1 ]
Ohashi, Manabu [1 ]
Sano, Takeshi [1 ]
机构
[1] Japanese Fdn Canc Res, Dept Surg Gastroenterol, Canc Inst Hosp, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan
[2] Hekinan Municipal Hosp, Dept Gen Surg, Hekinan, Aichi, Japan
关键词
Gastrectomy; Pancreatic atrophy; Pancreatic volumetry; MORPHOLOGICAL-CHANGES; INSUFFICIENCY; GHRELIN; REMNANT; VOLUME; PEPTIDE;
D O I
10.1007/s00595-020-02131-2
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose To investigate the phenomenon of pancreatic atrophy after gastrectomy for gastric cancer, using computed tomography (CT) volumetry. Methods The subjects of this retrospective study were 77 patients who underwent distal gastrectomy (DG) or total gastrectomy (TG) for pStage I gastric cancer in 2014. The relative pancreatic volume ratio was assessed preoperatively, and then 1 and 5 years postoperatively and the results were compared between surgical procedures Results A total of 14 patients underwent TG with Roux-en-Y (RY) reconstruction, 24 underwent DG with Billroth-I (BI) reconstruction, and 39 underwent DG with RY reconstruction. We observed that the pancreatic volume continued to decrease over the 5 years after DG or TG. Furthermore, the incidence of pancreatic atrophy 5 years postoperatively was significantly greater after TG than after DG. In patients who underwent DG, a greater incidence of pancreatic atrophy was observed after RY reconstruction than after BI reconstruction, 5 years postoperatively. Conclusion The pancreatic volume continued to decrease after DG and TG for gastric cancer 5 years after treatment. TG was associated with a significantly greater incidence of pancreatic atrophy than DG 5 years postoperatively, as was RY reconstruction vs. BI reconstruction after DG.
引用
收藏
页码:432 / 438
页数:7
相关论文
共 38 条
[1]   Effects of Ghrelin Administration After Total Gastrectomy: A Prospective, Randomized, Placebo-Controlled Phase II Study [J].
Adachi, Shinichi ;
Takiguchi, Shuji ;
Okada, Kazuyuki ;
Yamamoto, Kazuyoshi ;
Yamasaki, Makoto ;
Miyata, Hiroshi ;
Nakajima, Kiyokazu ;
Fujiwara, Yoshiyuki ;
Hosoda, Hiroshi ;
Kangawa, Kenji ;
Mori, Masaki ;
Doki, Yuichiro .
GASTROENTEROLOGY, 2010, 138 (04) :1312-1320
[2]  
Adair T. H., 2010, Control of Cardiac Output, V2, P1, DOI [10.4199/C00008ED1V01Y201002ISP006, DOI 10.4199/C00008ED1V01Y201002ISP006]
[3]   Pancreatic enzyme replacement therapy after gastric resection: An update [J].
Antonini, Filippo ;
Crippa, Stefano ;
Falconi, Massimo ;
Macarri, Giampiero ;
Pezzilli, Raffaele .
DIGESTIVE AND LIVER DISEASE, 2018, 50 (01) :1-5
[4]  
ARMBRECHT U, 1988, Alimentary Pharmacology and Therapeutics, V2, P493
[5]   NUTRIENT MALASSIMILATION AFTER TOTAL GASTRECTOMY AND POSSIBLE INTERVENTION [J].
ARMBRECHT, U ;
LUNDELL, L ;
STOCKBRUEGGER, RW .
DIGESTION, 1987, 37 :56-60
[6]  
Brägelmann R, 1999, EUR J GASTROEN HEPAT, V11, P231
[7]   Abnormalities of the Exocrine Pancreas in Type 1 Diabetes [J].
Campbell-Thompson, Martha ;
Rodriguez-Calvo, Teresa ;
Battaglia, Manuela .
CURRENT DIABETES REPORTS, 2015, 15 (10)
[8]   Pancreatic enzyme supplementation after gastrectomy for gastric cancer: a randomized controlled trial [J].
Catarci, Marco ;
Berlanda, Manuele ;
Grassi, Giovanni Battista ;
Masedu, Francesco ;
Guadagni, Stefano .
GASTRIC CANCER, 2018, 21 (03) :542-551
[9]  
Dominguez-Munoz J Enrique, 2009, HPB (Oxford), V11 Suppl 3, P3, DOI 10.1111/j.1477-2574.2009.00132.x
[10]   Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods [J].
Ferlay, J. ;
Colombet, M. ;
Soerjomataram, I. ;
Mathers, C. ;
Parkin, D. M. ;
Pineros, M. ;
Znaor, A. ;
Bray, F. .
INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (08) :1941-1953